Reports for BAXTER CORPORATION
Company Name
BAXTER CORPORATION
Totals |
||
Shortage reports |
229 |
|
| Actual shortage: | 5 (2%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 3 (1%) | |
| Resolved: | 221 (97%) | |
Discontinuation Reports |
29 |
|
| To be discontinued: | 2 (7%) | |
| Discontinued: | 27 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
14 (5%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PROPOFOL INJECTION | 10MG | EMULSION | Resolved | 2024-04-19 | 2024-05-03 | 225667 |
| UROMITEXAN | 100MG | SOLUTION | Resolved | 2024-03-11 | 2024-03-29 | 221778 |
| UROMITEXAN | 100MG | SOLUTION | Resolved | 2024-03-11 | 2024-03-29 | 221775 |
| METRONIDAZOLE INJECTION, USP | 5MG | SOLUTION | Resolved | 2024-02-27 | 2024-03-19 | 220718 |
| METRONIDAZOLE INJECTION, USP | 5MG | SOLUTION | Resolved | 2024-02-06 | 2024-02-08 | 218656 |
| POTASSIUM CHLORIDE INJECTION | 20mEq | SOLUTION LIQUID | Resolved | 2024-02-02 | 2024-02-15 | 218224 |
| PROCYTOX | 2000MG | POWDER FOR SOLUTION | Resolved | 2024-01-29 | 2024-02-28 | 217583 |
| UROMITEXAN | 100MG | SOLUTION | Resolved | 2023-12-27 | 2024-02-21 | 214355 |
| METRONIDAZOLE INJECTION, USP | 5MG | SOLUTION | Resolved | 2023-12-07 | 2024-02-02 | 212707 |
| METRONIDAZOLE INJECTION, USP | 5MG | SOLUTION | Resolved | 2023-12-07 | 2023-12-12 | 212704 |
| BUPIVACAINE HYDROCHLORIDE INJECTION, USP | 7.5MG | SOLUTION | Avoided shortage | 2023-11-17 | 2024-08-12 | 210780 |
| PROPOFOL INJECTION | 10MG | EMULSION | Avoided shortage | 2023-11-17 | 2024-05-03 | 210586 |
| PROPOFOL INJECTION | 10MG | EMULSION | Resolved | 2023-11-17 | 2024-01-10 | 210583 |
| PROPOFOL INJECTION | 10MG | EMULSION | Avoided shortage | 2023-11-17 | 2024-05-03 | 210580 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2023-10-11 | 2023-10-24 | 206816 |
| IFEX | 1G | POWDER FOR SOLUTION | Resolved | 2023-09-08 | 2023-10-10 | 203950 |
| UROMITEXAN | 100MG | SOLUTION | Resolved | 2023-09-08 | 2023-09-27 | 203947 |
| SODIUM CHLORIDE 3% INJ | 3G | SOLUTION | Resolved | 2023-07-06 | 2023-08-15 | 197763 |
| GENTAMICIN(E) | 1.6MG | SOLUTION | Resolved | 2023-07-06 | 2023-07-31 | 197760 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2023-07-06 | 2023-07-31 | 197756 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PROCYTOX | 200MG | POWDER FOR SOLUTION | To be discontinued | 2025-08-14 | 2025-08-14 | 265253 |
| PROCYTOX TAB 25MG | 25MG | TABLET | To be discontinued | 2025-08-14 | 2025-08-14 | 265250 |
| CLINIMIX | 520MG 1.04G 1.04G 290MG 290MG 310MG 310MG 5G 240MG 20MG 210MG 90MG 210MG 220MG 230MG | SOLUTION | Discontinued | 2025-04-10 | 2025-08-19 | 254830 |
| CLINDAMYCIN INJECTION IN 5% DEXTROSE | 300MG | SOLUTION | Discontinued | 2023-02-06 | 2023-04-02 | 183710 |
| 1.6% SODIUM CHLORDIE PROCESSING SOLUTION | 1.6G | SOLUTION SOLUTION | Discontinued | 2022-12-13 | 2023-01-01 | 178273 |
| POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 5G 900MG 300MG | SOLUTION | Discontinued | 2020-11-26 | 2021-02-02 | 128947 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120961 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120958 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120955 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120952 |
| CIPROFLOXACIN INJECTION | 2MG | SOLUTION | Discontinued | 2020-07-21 | 2020-08-17 | 120710 |
| CLINIMIX | 200MG 300MG 290MG 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG 16.6G 365MG 280MG 290MG | SOLUTION | Discontinued | 2020-06-22 | 2022-12-08 | 118612 |
| CLINIMIX E | 205MG 261MG 58.5MG 24MG 16.6G 365MG 280MG 290MG 200MG 300MG 290MG 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG | SOLUTION | Discontinued | 2020-06-22 | 2022-06-30 | 118607 |
| CLINIMIX E | 90MG 210MG 20MG 261MG 58.5MG 24MG 205MG 20G 310MG 310MG 290MG 290MG 1.04G 1.04G 520MG 240MG 230MG 220MG 210MG | SOLUTION | Discontinued | 2020-06-22 | 2021-03-26 | 118604 |
| CLINIMIX | 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG 10G 365MG 280MG 290MG 200MG 300MG 290MG | SOLUTION | Discontinued | 2020-06-22 | 2022-04-20 | 118601 |
| NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Discontinued | 2019-08-12 | 2020-06-02 | 91385 |
| NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Discontinued | 2019-08-12 | 2020-06-02 | 91382 |
| NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Discontinued | 2019-08-12 | 2020-06-02 | 91378 |
| ACID CONCENTRATE D12306 | 45G 10.8G 1.61G 7.49G 263G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7267 |
| ACID CONCENTRATE D12304 | 90G 10.8G 1.61G 7.48G 263G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7264 |